- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06397066
White Light Endoscopy and Magnifying Endoscopy in Assessing the Status of Hp Infection
Comparative Study of White Light Endoscopy and Magnifying Endoscopy in Assessing the Status of Helicobacter Pylori Infection
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This study adopts a cross-sectional study. The expected recruitment time for all participants is 12 months. Our endoscopy center conducts magnifying staining endoscopy examination, along with endoscopic Hp immunohistochemical testing, and cases that have recently completed carbon-13 or carbon-14 breath tests.
1.Retrospectively enrolled cases from August 1, 2022 to April 30, 2024, who underwent magnifying endoscopic examination with endoscopic Hp immunohistochemical testing result at the Endoscopy Center of the First Hospital of Jilin University. All enrolled cases had carbon-13 or carbon-14 breath tests, excluding cases of total gastric atrophy and endoscopic type A gastritis. The criteria for determining the status of Hp infection: A positive immunohistochemical or 13/carbon-14 breath test result indicates a current Hp infection. If both of immunohistochemical or 13/carbon-14 breath test result are negative, combined with the treatment history for Hp infection and endoscopic manifestations, they are further classified as non-infection or past H. pylori infection. If there is a treatment history for Hp infection or obvious atrophy under the endoscopy in which atrophy degree greater than or equal to Kimura-Takemoto classification C2 ( atrophy exceeding the gastric angle), it is considered as past H. pylori infection. If there is no such manifestation, it is considered Hp non-infection. Extract the relevant characteristics of Hp infection under white light and magnifying endoscopy from continuous inclusion of cases, and determine the Hp infection status separately. The characteristics of white light endoscopic extraction include degree of atrophy (Kimura-Takemoto classification), congestion and edema, yellow white nodules, mucus turbidity, the arrangement of the collecting veins is regular (RAC)/irregular/disappearing, goose flesh, map-like redness, blood scabs, gastric fundus gland polyps, and scratch syndrome, and are judged according to the Kyoto Classification of Gastritis. Magnifying endoscopy uses NBI+ME to observe the non atrophic area of the gastric fundus gland. According to the proportion of the opening of the gastric fundus gland duct in one magnified field of view, it is classified as grade 1 ≤ 25%, indicating Hp current infection, 25%<grade 2<50%, Hp uncertain state, indicating Hp current infection or after recent sterilization, grade 3 ≥ 50%, indicating Hp non-infection or past H. pylori infection. The investigators conduct a comparative study between white light endoscopy and magnifying endoscopy, and conduct subgroup analysis based on Hp infection status.
Based on the characteristics of white light endoscopy and magnifying endoscopy, summarize and sort out the integrated endoscopic Hp infection status judgment process (named the integrated endoscopic judgment).
Prospective enrollment: From May 1, 2024 to December 31, 2024, patients who underwent magnifying endoscopic examination with endoscopic Hp immunohistochemical testing result at the Endoscopy Center of the First Hospital of Jilin University. All enrolled cases had carbon-13 or carbon-14 breath tests, excluding cases of total gastric atrophy and endoscopic type A gastritis. Using the white light endoscopy, magnifying endoscopy, and integrated endoscopic judgment to determine the Hp infection status, three different endoscopic Hp judgment results will be obtained, and data comparison conducted between the three groups.
All enrolled cases were evaluated blindly by two doctors. If there was no consensus, the third doctor would further evaluate and determine the Hp infection status under white light endoscopy, magnifying endoscopy, and integrated endoscopic judgment. Based on the comparison results, a more accurate endoscopic method will be selected to determine the Hp infection status.
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Dong Yang, doctor
Study Contact Backup
- Name: Dong Yang, doctor
- Phone Number: 18844097668
- Email: 18844097668@163.com
Study Locations
-
-
Ji Lin
-
Chang chun, Ji Lin, China, 130021
- Recruiting
- The First Hospital of Jilin University
-
Contact:
- Dong Yang, Master
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Our endoscopy center conducts magnifying staining endoscopy examination, along with endoscopic Hp immunohistochemical testing, and cases that have recently completed carbon-13 or carbon-14 breath tests.
Exclusion Criteria:
- Total gastric atrophy and endoscopic type A gastritis.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
the white light endoscopy group
The characteristics of white light endoscopic extraction include degree of atrophy (Kimura-Takemoto classification), congestion and edema, yellow white nodules, mucus turbidity, the arrangement of the collecting veins is regular (RAC)/irregular/disappearing, goose flesh, map-like redness, blood scabs, gastric fundus gland polyps, and scratch syndrome, and are judged according to the Kyoto Classification of Gastritis.
|
White light endoscopy observe the characteristics of mucosa under white light
|
|
the Magnifying endoscopy group
Magnifying endoscopy(ME) uses Narrow Band Imaging (NBI)+ME to observe the non atrophic area of the gastric fundus gland.
According to the proportion of the opening of the gastric fundus gland duct in one magnified field of view, it is classified as grade 1 ≤ 25%, indicating Hp current infection, 25%<grade 2<50%, Hp uncertain state, indicating Hp current infection or after recent sterilization, grade 3 ≥ 50%, indicating Hp non-infection or past H. pylori infection.
|
NBI+ME to observe the non atrophic area of the gastric fundus gland.
The results depend on the ratio of gastric fundus gland.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Accuracy of different observation method
Time Frame: at the end of the observation of endoscopy procedure
|
white light endoscopy, magnifying endoscopy, and integrated endoscopic judgment to determine the status of Hp infection (including Hp current infection, Hp negative, and past H. pylori infection status)
|
at the end of the observation of endoscopy procedure
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
result of immunohistochemistry
Time Frame: the end of enrollment
|
Biopsy of Helicobacter pylori from the large and small curvature of the gastric antrum and the large and small curvature of the gastric body, and submission for immunohistochemical detection
|
the end of enrollment
|
|
result of breath tests.
Time Frame: the end of enrollment
|
the results of carbon-13 or carbon-14 breath tests showed the Hp infection status
|
the end of enrollment
|
|
Sensitivity of different observation method
Time Frame: at the end of the observation of endoscopy procedure
|
white light endoscopy, magnifying endoscopy, and integrated endoscopic judgment to determine the status of Hp infection (including Hp current infection, Hp negative, and past H. pylori infection)
|
at the end of the observation of endoscopy procedure
|
|
specificity of different observation method
Time Frame: at the end of the observation of endoscopy procedure
|
white light endoscopy, magnifying endoscopy, and integrated endoscopic judgment to determine the status of Hp infection (including Hp current infection, Hp negative, and past H. pylori infection)
|
at the end of the observation of endoscopy procedure
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Dong Yang, doctor, The First Hospital of Jilin University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 130028
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Helicobacter Pylori Infection
-
Second Affiliated Hospital, School of Medicine,...CompletedHelicobacter Pylori Infection | Helicobacter Pylori Eradication AntibioticChina
-
Tanta UniversityRecruitingHELICOBACTER PYLORI INFECTIONS | Helicobacter Infection | Helicobacter Pylori Gastrointestinal Tract Infection | Helicobacter Pylori Infected PatientsEgypt
-
Christopher C. Thompson, MD, MScErbe Elektromedizin GmbHRecruitingHelicobacter Pylori Infection | H. Pylori Infection | Helicobacter Pylori | Helicobacter Pylori Gastrointestinal Tract Infection | H. Pylori Gastrointestinal DiseaseUnited States
-
Daewoong Pharmaceutical Co. LTD.iNtherapeutics Co. LTDCompletedHelicobacter Pylori Infection | Helicobacter Pylori Infected Subjects | Helicobacter Pylori Infected PatientsSouth Korea
-
First People's Hospital of HangzhouRecruiting
-
Shanghai Jiao Tong University School of MedicineRecruiting
-
Peking University First HospitalRecruitingHelicobacter Pylori InfectionChina
-
Shanghai Zhongshan HospitalNot yet recruiting
-
Kaohsiung Medical UniversityKaohsiung Veterans General Hospital.RecruitingHelicobacter Pylori InfectionTaiwan
-
Yueyue LiQilu Hospital of Shandong University; Shandong University of Traditional Chinese... and other collaboratorsRecruitingHelicobacter Pylori InfectionChina
Clinical Trials on Magnifying endoscopy group
-
Changhai HospitalWest China Hospital; Shandong Provincial Hospital; The First Affiliated Hospital... and other collaboratorsNot yet recruitingEsophageal Neoplasms MalignantChina
-
Soonchunhyang University HospitalCompleted
-
Shandong UniversityUnknownEarly Gastric CancerChina
-
Yonsei UniversityUnknownEarly Gastric Cancer | Gastric Dysplasia | Gastric Adenoma
-
Sun Yat-sen UniversityZhejiang Cancer Hospital; Shandong Cancer Hospital and Institute; Xinqiao Hospital... and other collaboratorsRecruiting
-
West China Second University HospitalNot yet recruiting
-
Affiliated Hospital to Academy of Military Medical...Unknown
-
Chinese University of Hong KongRecruiting
-
Shandong Provincial HospitalShandong UniversityCompleted
-
Shandong Provincial HospitalSecond Affiliated Hospital of Zhengzhou UniversityActive, not recruiting